ESR1 and breast cancer: In line with this, a study by Robinson and colleagues [8] performed on the ER−/AR+ MDA-MB-453 cell line revealed that the AR-binding profile is similar to that of ER in BC cells and that AR functionality depends on FOXA1 since its silencing inhibits AR-binding.